Phio Pharmaceuticals Corp. (PHIO) Free cash flow 2016–2025
Phio Pharmaceuticals Corp. (PHIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$8.0MFY2025 · since FY2016: -$7.8M → -$8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.0M | -12.3% |
| FY2024 | -$7.1M | +33.9% |
| FY2023 | -$10.8M | +12.2% |
| FY2022 | -$12.3M | -2.9% |
| FY2021 | -$11.9M | -35.0% |
| FY2020 | -$8.8M | -1.2% |
| FY2019 | -$8.7M | -15.8% |
| FY2018 | -$7.5M | +22.6% |
| FY2017 | -$9.7M | -25.2% |
| FY2016 | -$7.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PHIO financial trends
PHIO RevenuePHIO Net incomePHIO Net marginPHIO Gross profitPHIO Gross marginPHIO Operating incomePHIO Operating marginPHIO Operating cash flowPHIO Capital expendituresPHIO Return on equityPHIO Stock buybacksPHIO Dividends paidPHIO Total assetsPHIO Total liabilitiesPHIO Shareholders’ equityPHIO overview →